During ESMO 2022, Prof Dr Naoto Ueno (University of Hawaii Cancer Center,...
During ESMO 2024, Dr Eva Ciruelos, medical oncologist at the Hospital...
Since the publication of the PACIFIC trial, chemoradiotherapy followed by...
The STELLAR 305 clinical trial is a phase 2/3 randomised study comparing...
The PEMDA Head and Neck trial investigates the efficacy of a STAT3 inhibitor....
The KEYNOTE-859 study investigated the efficacy of pembrolizumab combined with...
Mitazalimab, a human CD40 agonistic IgG1 antibody, shows promise by reducing...
Professor Wakelee from Stanford, United States, presented the final DFS...
The final analysis of the DESTINY-Lung02 trial, a dose-blinded phase 2...
The VENUS study is a prospective translational single-institution study that...